Finance

Lists
CRMD:NASDAQ
CorMedix Inc
US$7,46
+1,08%
(+0,080) 1D
US$7,54
+1,07% (+0,080)
After hours
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRMD...
Open
US$7,41
High
US$7,60
Low
US$7,16
Mkt. cap
581,46 ລ້ານ
Avg. vol.
896,12 ພັນ
Volume
1,59 ລ້ານ
P/E ratio
3,50
52-wk high
US$13,02
52-wk low
US$6,12
EPS
US$2,13
Beta
1,40
Shares outstanding
77,94 ລ້ານ
No. of employees
191
Open
US$7,41
High
US$7,60
Low
US$7,16
Mkt. cap
581,46 ລ້ານ
Avg. vol.
896,12 ພັນ
Volume
1,59 ລ້ານ
P/E ratio
3,50
52-wk high
US$13,02
52-wk low
US$6,12
EPS
US$2,13
Beta
1,40
Shares outstanding
77,94 ລ້ານ
No. of employees
191
News stories
From web sources and news partners
About CorMedix Inc
CEO-
Employees191
Founded2006
HeadquartersBerkeley Heights, ນິວເຈີຊີ, ສະຫະລັດ
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to CRMD in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRMD in the last 3 months.
Highest
Current US$7,46
US$15,00 (+101,07%)
Average
US$14,25 (+91,02%)
Lowest
US$13,00 (+74,26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Buy
Maintained
US$14,00
+87,7%
10/08/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
US$15,00
+101,1%
09/23/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
US$13,00
+74,3%
08/14/2026
Serge Belanger
Needham
Buy
Maintained
US$15,00
+101,1%
08/13/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
US$15,00
+101,1%
05/15/2026
Les Sulewski
Truist Financial
Buy
Maintained
-
-
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
104,28 ລ້ານ
128,62 ລ້ານ
127,43 ລ້ານ
101,93 ລ້ານ
Cost of goods sold
7,57 ລ້ານ
11,17 ລ້ານ
12,00 ລ້ານ
14,50 ລ້ານ
Cost of revenue
7,57 ລ້ານ
11,17 ລ້ານ
12,00 ລ້ານ
14,50 ລ້ານ
Research and development expenses
5,10 ລ້ານ
8,60 ລ້ານ
7,21 ລ້ານ
6,68 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,64 ລ້ານ
29,38 ລ້ານ
34,25 ລ້ານ
27,53 ລ້ານ
Operating expense
45,36 ລ້ານ
48,12 ລ້ານ
51,76 ລ້ານ
44,52 ລ້ານ
Total operating expenses
52,93 ລ້ານ
59,29 ລ້ານ
63,77 ລ້ານ
59,02 ລ້ານ
Operating income
51,35 ລ້ານ
69,33 ລ້ານ
63,66 ລ້ານ
42,91 ລ້ານ
Other non operating income
-
-
-268,00 ພັນ
-71,00 ພັນ
EBT including unusual items
52,58 ລ້ານ
56,45 ລ້ານ
55,64 ລ້ານ
38,73 ລ້ານ
EBT excluding unusual items
51,89 ລ້ານ
68,47 ລ້ານ
63,39 ລ້ານ
42,84 ລ້ານ
Income tax expense
-55,99 ລ້ານ
42,43 ລ້ານ
17,04 ລ້ານ
12,74 ລ້ານ
Effective tax rate
-106,49%
75,16%
30,63%
32,90%
Other operating expenses
-
-
-
-
Net income
108,56 ລ້ານ
14,02 ລ້ານ
38,60 ລ້ານ
25,99 ລ້ານ
Net profit margin
104,11%
10,90%
30,29%
25,50%
Earnings per share
1,41
0,16
0,35
-
Interest and investment income
1,56 ລ້ານ
889,98 ພັນ
-
-
Interest expense
-948,24 ພັນ
-1,82 ລ້ານ
-
-
Net interest expenses
612,03 ພັນ
-927,10 ພັນ
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
55,14 ລ້ານ
79,76 ລ້ານ
74,20 ລ້ານ
53,45 ລ້ານ
Gain or loss from assets sale
-
-86,00 ພັນ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google